⚠️ Serious warning: Nothing on this website is approved by any physician. Doz is only a tool to help physicians and to search drugs easily. Taking medicines without medical supervision can be fatal.
Naphazoline + pheniramine eye drops
قطره چشمی نافازولین + فنیرامین
👁️ Sensory OrgansOcular decongestant + antihistamine
🤰 Pregnancy:Use with caution 🇮🇷 Registered in Iran⛔ 2 contraindications 🇺🇸 FDA approved (NDA) NDA020065ATC S01GA51
Market / country: 🇺🇸 USA
Naphcon-A (US) · Visine-A (US)
🧮 Dose calculator
Allergic conjunctivitis · Regimen source: FDA Naphazoline+phenir. · Directions
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⚠️ Narrow-angle glaucoma, heart disease, high blood pressure, enlarged prostate: ask a doctor first. FDA Naphazoline+phenir. · Warnings — Ask a doctor before use
- ⚠️ Under 6 years: ask a doctor. FDA Naphazoline+phenir. · Directions
Warnings
- • Overuse may cause more redness; pupils may dilate temporarily. FDA Naphazoline+phenir. · Warnings — When using this product
Formulations
- Naphazoline 0.02675% + pheniramine 0.315% — eye drops 🇺🇸 USA FDA Naphazoline+phenir. · Active Ingredients
👥 Special populations
- 🤰 PregnancyUse with caution
Darooyab: category C — only if benefit outweighs risk. Darooyab · G-2201/Naphazoline — مصرف در بارداری
“مصرف در بارداری نفازولین گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:”
- 🤱 BreastfeedingNo data
The source for this drug has no section for this group.
- 👶 ChildrenNo data
The source for this drug has no section for this group.
- 👴 Older adultsNo data
The source for this drug has no section for this group.
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA020065
- DailyMed (FDA label)FDA Naphazoline+phenir.
- MedlinePlus (NIH)❌ None
- WHO ATC/DDDS01GA51
- Darooyab (Iran)Naphazoline
🇮🇷 Registered in Iran Darooyab · G-2201/Naphazoline
Dosage forms with Iranian generic codes, per Darooyab.
- 00886 · NAPHAZOLINE 0.05% 10ML NASAL DROP · قطره بینی نافازولین ۰٫۰۵ درصد ۱۰ میلی‌لیتر
- 11861 · NAPHAZOLINE 0.05% NASAL SPRAY · اسپری بینی نافازولین ۰٫۰۵ درصد
- 00887 · NAPHAZOLINE 0.1% 10ML OPH DROP · قطره چشمی نافازولین ۰٫۱ درصد ۱۰ میلی‌لیتر
- 51887 · NAPHAZOLINE HYDROCHLORIDE SPRAY NASAL 0.05 % 15 mL · اسپری بینی نافازولین هیدروکلراید ۰٫۰۵ درصد ۱۵ میلی‌لیتر
- 52233 · NAPHAZOLINE HYDROCHLORIDE SOLUTION, DROPS OPHTHALMIC 0.1 % 0.5 mL · قطره چشمی نافازولین هیدروکلراید ۰٫۱ درصد ۰٫۵ میلی‌لیتر
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Naphazoline+phenir. · Active IngredientsFDA Naphazoline+phenir. · DirectionsFDA Naphazoline+phenir. · Warnings — Ask a doctor before useFDA Naphazoline+phenir. · Warnings — When using this productFDA Naphazoline+phenir. · SPL approval / marketing category
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-2201/NaphazolineDarooyab · G-2201/Naphazoline — مصرف در بارداری
- Clinical review⚠ Unverified